Literature DB >> 22379282

Improving the tracking and removal of retrievable inferior vena cava filters.

Anthony D Goei, Shellie C Josephs, Thomas B Kinney, Charles E Ray, David Sacks.   

Abstract

Therapeutic and prophylactic inferior vena cava (IVC) filters should be placed based on currently accepted indications to prevent a fatal pulmonary embolism (PE). The protective effect of filters is offset by the potential for lower extremity deep venous thrombosis (DVT), caval thrombosis, and possible otherwise unnecessary life-long anticoagulation (AC). The duration of treatment for most DVTs or PEs is 3 to 6 months of AC/filter. Filters should be retrieved when duration of treatment for a DVT/PE has been met, the risk of a PE is no longer high, and/or there is no longer a contraindication to AC. An effective system that leads to improving the retrieval rate of filters must include education of the patient, a tracking system to minimize patient lost to follow-up, and dedicated personnel to oversee the process. If these goals are accomplished, interventionalists can help decrease the incidence of a fatal PE during the high-risk period, and also decrease the risk of a DVT or the use of otherwise unnecessary life-long AC in subsequent years. Currently, there is much room for improvement in the frequency that IVCF patients are systematically followed and filters are retrieved. The principles discussed in this report will be helpful in this process.

Entities:  

Keywords:  Retrievable inferior vena cava filters; improving retrieval of inferior vena cava filters; tracking inferior vena cava filter patients

Year:  2011        PMID: 22379282      PMCID: PMC3140247          DOI: 10.1055/s-0031-1273946

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  18 in total

1.  Use of emboli-blocking filters increases, but rigorous data are lacking.

Authors:  Erin Brender
Journal:  JAMA       Date:  2006-03-01       Impact factor: 56.272

2.  Outcomes with retrievable inferior vena cava filters: a multicenter study.

Authors:  Charles E Ray; Erica Mitchell; Stan Zipser; Edward Y Kao; Charles F Brown; Greg L Moneta
Journal:  J Vasc Interv Radiol       Date:  2006-10       Impact factor: 3.464

3.  A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.

Authors:  H Decousus; A Leizorovicz; F Parent; Y Page; B Tardy; P Girard; S Laporte; R Faivre; B Charbonnier; F G Barral; Y Huet; G Simonneau
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

4.  The safety and effectiveness of the retrievable option inferior vena cava filter: a United States prospective multicenter clinical study.

Authors:  Matthew S Johnson; Albert A Nemcek; James F Benenati; Dirk S Baumann; Bart L Dolmatch; John A Kaufman; Mark J Garcia; Michael S Stecker; Anthony C Venbrux; Ziv J Haskal; Rui L Avelar
Journal:  J Vasc Interv Radiol       Date:  2010-07-03       Impact factor: 3.464

5.  Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study.

Authors: 
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

6.  Optional inferior vena cava filters in the trauma patient.

Authors:  Hamed Aryafar; Thomas B Kinney
Journal:  Semin Intervent Radiol       Date:  2010-03       Impact factor: 1.513

7.  A prospective study of venous thromboembolism after major trauma.

Authors:  W H Geerts; K I Code; R M Jay; E Chen; J P Szalai
Journal:  N Engl J Med       Date:  1994-12-15       Impact factor: 91.245

8.  Vena cava filter retrieval in therapeutically anticoagulated patients.

Authors:  Thomas M Schmelzer; A Britton Christmas; Dennis A Taylor; B Todd Heniford; Ronald F Sing
Journal:  Am J Surg       Date:  2008-12       Impact factor: 2.565

9.  Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Clive Kearon; Susan R Kahn; Giancarlo Agnelli; Samuel Goldhaber; Gary E Raskob; Anthony J Comerota
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

10.  The increasing use of vena cava filters in adult trauma victims: data from the American College of Surgeons National Trauma Data Bank.

Authors:  Steven R Shackford; Alan Cook; Frederick B Rogers; Benjamin Littenberg; Turner Osler
Journal:  J Trauma       Date:  2007-10
View more
  6 in total

1.  Renal artery stenosis on duplex ultrasound due to inferior vena cava filter leg impingement.

Authors:  Kathleen Hannon
Journal:  Ultrasound       Date:  2014-08-19

2.  Inferior vena cava filtration in the management of venous thromboembolism: filtering the data.

Authors:  Christopher Molvar
Journal:  Semin Intervent Radiol       Date:  2012-09       Impact factor: 1.513

Review 3.  Inferior vena cava filters: current best practices.

Authors:  Anita Rajasekhar
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

4.  Robotic-Assisted Inferior Vena Cava Filter Retrieval.

Authors:  Shahin Owji; Tony Lu; Thomas M Loh; Adeline Schwein; Alan B Lumsden; Jean Bismuth
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Jan-Mar

5.  Non-retrieval of inferior vena cava filters as a patient safety concern: evaluation of a new process improvement project to increase retrieval rates in a vascular and interventional radiology clinic.

Authors:  Joshua Brown; Jeffery Talbert; Ryan Pennington; Qiong Han; Driss Raissi
Journal:  Patient Saf Surg       Date:  2018-03-20

6.  Venous thromboembolism prophylaxis in the trauma intensive care unit: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document.

Authors:  Joseph F Rappold; Forest R Sheppard; Samuel P Carmichael Ii; Joseph Cuschieri; Eric Ley; Erika Rangel; Anupamaa J Seshadri; Christopher P Michetti
Journal:  Trauma Surg Acute Care Open       Date:  2021-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.